1. Introduction {#sec1}
===============

Asthma is a complex chronic inflammatory disease that results from the interaction between genetic predisposition and environmental factors \[[@B1]\]. More than 300 million persons worldwide were affected by this airways disease, with approximately 250,000 annual deaths as a result \[[@B2]\]. It has also been estimated that the number of asthmatic patients will increase by 2015 for more than 100 million \[[@B3]\]. Multiple interacting genes have been involved in causing this disease and contributing to the disease pathogenesis and other genes have a protective effect. Each gene may have its own tendency to be influenced by environment factors \[[@B4]\]. However, the identified asthma susceptibility genes have increased rapidly over the last 5 years, especially when genome wide association (GWA) study approach has been applied \[[@B1]\]. Interleukin 4 was originally discovered as a low molecular weight T cell-derived polypeptide of 129 amino acids, which is encoded by the*IL-4* gene located on chromosome 5q23.31:*IL-4* \[[@B5]\]. Closer to this chromosomal region (5q31-q33), asthma and atopy susceptibility gene(s) have been mapped by numerous genetic studies in several ethnic populations: Dutch \[[@B6], [@B7]\], Amish \[[@B8]\], American Caucasian \[[@B9]\], Hutterite \[[@B10]\], and British \[[@B11], [@B12]\]. The role that interleukin-4 plays in the pathogenesis of asthma has been indicated from actively sensitized IL-4 knockout mice \[[@B13], [@B14]\]. Studies on T helper 2 (Th2) cytokines in asthma have focused on IL-4 and IL-5 and this is due to the crucial role of these two cytokines in Th2 generation responses in a variety of animal models. IL-4 is essential for the maturation of native T cells toward Th2 cells and production of IgE \[[@B15], [@B16]\]. Polymorphisms in genes play key roles in regulation of cytokines expression; for example, substitution of C by T at the position −590 of*IL4* gene has been reported to be associated with a reduced*IL4* expression, while the TT genotype upregulated the production of this cytokine \[[@B17]\]. This work is the first investigation in Iraq that dealt with genotyping of*IL4* −590 (C\>T) in a sample of Iraqi asthmatic patients with the aim to determine its susceptibility role.

2. Material and Methods {#sec2}
=======================

2.1. Subjects {#sec2.1}
-------------

Forty-eight asthma patients and 25 controls (healthy) subjects were enrolled in the study. The patients were referred to the Al Zahra Center for Allergy and Asthma in Baghdad, Iraq, for diagnosis and treatment. The diagnosis was made by the consultant medical staff according to international criteria. All cases and controls were at the age range 10--65 years. Anticoagulants EDTA tubes were used for collecting the peripheral blood for DNA isolation.

2.2. Genotyping {#sec2.2}
---------------

DNA from venous blood was isolated using ReliaPrep™ Blood gDNA Miniprep System kit (Promega). The*IL-4* gene at position −590 (C\>T) was genotyped using the amplification refractory mutation system (ARMS-PCR) approach. Primers for this position were used according to \[[@B18]\] and synthesized at Alpha DNA Company (Canada) ([Table 1](#tab1){ref-type="table"}).

2.3. ARMS-PCR {#sec2.3}
-------------

ARMS-PCR approach was used for genotyping of*IL4* −590 (C\>T). AccuPower® PCR PreMix (Bioneer, Korea) was prepared according to \[[@B18]\] with some modifications. The primers and DNA template were added to PCR PreMix tubes and the final volume for PCR reaction was made up to 20 *μ*L with nuclease-free water ([Table 2](#tab2){ref-type="table"}). The reaction mixers were placed in thermal cycler (Esco, Singapore), and PCR conditions for the all reaction mixers are described in [Table 3](#tab3){ref-type="table"}.

The products of PCR were resolved on 1.5% agarose gels. The DNA 100 bp ladder (Bioneer, Korea) was also loaded on the agarose gel. Two microliters of bromophenol blue dye was loaded with all reaction mixer samples. The gel electrophoresis was performed by using 75 V for 2 hrs and stained with ethidium bromide (Promega, USA) for 30 min. The gel was documented with gel documentation system (Biocom, USA).

2.4. Statistical Analysis {#sec2.4}
-------------------------

Percentage frequencies and significant differences data between patients and controls were given by Fisher\'s exact test. The odds ratio (OR) and confidence intervals (CI) were analyzed by using Compare 2 Ver.3.04 program designed by J. H. Abramson/2003--2013. Deviations from Hardy-Weinberg were tested using an exact test available at <http://www.had2know.com/academics.html>.

3. Results and Discussion {#sec3}
=========================

By using ARMS-PCR, the polymorphism of*IL4* −590 (C\>T) showed the presence of*C*and*T* alleles and three genotypes (CC, CT, and TT) by using the specific*C*, specific*T,*and reverse primers ([Figure 1](#fig1){ref-type="fig"}).

Genotype frequencies of*IL4*-590 (C\>T) were in a good agreement with Hardy-Weinberg equilibrium in asthma patients and controls, as there were no significant differences between observed and expected genotype frequencies ([Table 4](#tab4){ref-type="table"}).

The*C*allele showed a significant increased frequency in patients compared to controls (92.71 versus 58%). In contrast, the*T* allele frequency was significantly higher in controls (42%) than in patients (7.29%). The OR for*C* and*T* alleles were 9.21 and 0.11, respectively. Such results suggest that*C* allele has a predisposing effect, while*T* allele has a protective effect ([Table 5](#tab5){ref-type="table"}). In terms of genotype frequencies, CC genotype was observed to have a significant increased frequency in patients compared to controls (87.5 versus 32%), while CT and TT genotype frequencies were significantly decreased in patients (10.42% and 2.08%, respectively) compared to controls (52% and 16%, respectively). The OR for CC, CT, and TT genotypes was 14.88, 0.11, and 0.11, respectively ([Table 6](#tab6){ref-type="table"}). An increased risk of asthma might be associated with CC genotype, while the genotypes CT and TT are thought to have a protective effect from asthma.

Studies of candidate-genes have examined the involvement of many genes in asthma and allergy and demonstrated a role for more than 100 loci. Several themes that regard biology and pathogenesis of these diseases have elucidated by these studies. Traditional linkage analyses revealed a small number of genes that are associated with asthma or allergy \[[@B19]\].

Cytokines are key mediators that regulate innate and adaptive immune responses, which are also subjected to the effect of factors such as infection, inflammation, and hormonal condition. However, cytokine gene polymorphisms have a role in the expression of cytokines by immune cells \[[@B20]\]. The*C* allele frequency in asthma patients was higher in comparison with*T* allele and this refers to the role of CC genotype in the development of the disease, but these results need more evidences for confirming and also need more immunological studies such as detecting the level of IL-4 in sera of asthma patients. In a Dutch study of gene-gene interaction in asthma, Howard et al. \[[@B21]\] observed significant associations of atopy and asthma with several*IL4RA*polymorphisms, including S478P and total serum IgE levels (*P* = 0.0007). A further study carried out by Xiaoyan et al. \[[@B22]\] investigated six gene loci (one of them is of*IL4*-590), and the authors suggested that these genes make little contribution to the development of asthma in children of Chinese Han nationality.

4. Conclusions {#sec4}
==============

In conclusion, the increasing risk of asthma was associated with*C*allele and the CC genotype, while the*T* allele and CT and TT genotypes were present more in healthy subjects which are thought to have a protective effect (preventive fraction). These alleles dominating in special population compared to others at genetic levels could be used as an indicator of genetic biomarkers that effect on either pathogenesis or protection from the diseases.
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![Gel electrophoresis for the*IL-4* gene −590 (C\>T) showing the*C*and*T* alleles in some asthma patients. (Gel electrophoresis was done by using 1.5% agarose gel concentration, 75 volts for 2 hours. Presence of one band in*C*lane and absence of this band in*T* lane refer to the genotype CC. In contrast, presence of one band in*T*lane and absence of this band in*C* lane refer to the genotype TT. Presence of two bands in both lanes refers to the genotype CT.)](DM2017-5806236.001){#fig1}

###### 

Primers for *IL-4* −590 (C\>T) genotyping.

  Primer     Sequence (5′ → 3′)                Product size (bp)
  ---------- --------------------------------- -------------------
  T allele   5′-ACACTAAACTTGGGAGAACATTGTT-3′   216
  C allele   5′-ACACTAAACTTGGGAGAACATTGTC-3′   248
  Reverse    5′-GAATTTGTTAGTAATGCAGTCCTCC-3′   ---

###### 

PCR mix reaction for genotyping of *IL-4* gene position −590 (C\>T).

  Component                                    Volume (*μ*l)   Final concentration
  -------------------------------------------- --------------- ---------------------
  Each primer (T or C allele + reverse)^*∗*^   2               1 *μ*M
  DNA template                                 5               100 ng
  Nuclease-free water                          11              ---
  Final volume                                 20              ---

^**∗**^T and reverse primers were used for detecting *T* allele; *C* and reverse primers were used for detecting *C* allele.

###### 

PCR conditions for genotyping of *IL-4* gene position −590 (C\>T).

  Steps                         Temperature (°C) and cycles   Time (sec)   
  ----------------------------- ----------------------------- ------------ ----
  Denature template             96                            60           
  First initial denaturation    95                            10 cycles    15
  First annealing               65                            50           
  First extension               72                            40           
  Second initial denaturation   95                            20 cycles    50
  Second annealing              59                            50           
  Second extension              72                            50           
  Final extension               72                            7 min        
  Incubation                    4                             5 min        

###### 

Hardy-Weinberg distribution of *IL4* −590 (C\>T) genotypes in asthma patients and controls.

  Gene                 Genotype    Observed asthma patients number (%)   Expected asthma patients number (%)   Observed controls number (%)   Expected controls number (%)
  -------------------- ----------- ------------------------------------- ------------------------------------- ------------------------------ ------------------------------
  *IL-4* −590 (C\>T)   CC          42 (87.5)                             (85.95) 41.26                         8 (32)                         (33.64) 8.41
  CT                   5 (10.42)   (13.52) 6.49                          13 (52)                               (48.72) 12.18                  
  TT                   1 (2.08)    (0.53) 0.26                           4 (16)                                (%17.64) 4.41                  
  *P* value            0.1118      0.7364                                                                                                     

###### 

Allele frequencies of *IL4* −590 (C\>T) in asthma patients and controls.

  Gene position        Allele     Asthma patients number (%)   Controls number (%)     OR (95% CI)              *P* value
  -------------------- ---------- ---------------------------- ----------------------- ------------------------ ---------------
  *IL-4* −590 (C\>T)   *C*        (92.71) 89                   \(58\) 29               9.21 (IC = 3.58−23.71)   1 × 10^−6*∗*^
  EF                   0.826                                                                                    
  *T*                  (7.29) 7   \(42\) 21                    0.11 (IC = 0.04−0.28)   1 × 10^−6*∗*^            
  PF                   0.374                                                                                    

OR = odds ratio, CI = confidence intervals, EF = etiological fraction, and PF = preventive fraction. ^*∗*^Significant differences at *P* \< 0.05 level by using Fisher\'s test.

###### 

Frequency distribution of *IL4* −590 (C\>T) genotypes in asthma patients and controls.

  Gene                 Genotype    Asthma patients number (%)   Controls number (%)     OR (95% CI)               *P* value
  -------------------- ----------- ---------------------------- ----------------------- ------------------------- --------------
  *IL-4* −590 (C\>T)   CC          42 (87.5)                    8 (32)                  14.88 (IC = 4.57−48.45)   2.5 × 10^−6^
  EF                   0.816                                                                                      
  CT                   5 (10.42)   13 (52)                      0.11 (IC = 0.03−0.35)   3.1 × 10^−4^              
  PF                   0.464                                                                                      
  TT                   1 (2.08)    4 (16)                       0.11 (IC = 0.01−1.03)   0.044                     
  PF                   0.142                                                                                      

OR = odds ratio, CI = confidence intervals, EF = etiological fraction, and PF = preventive fraction.
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